Metformin-mediated effects on mesenchymal stem cells and mechanisms: proliferation, differentiation and aging

Mesenchymal stem cells (MSCs) are a type of pluripotent adult stem cell with strong self-renewal and multi-differentiation abilities. Their excellent biological traits, minimal immunogenicity, and abundant availability have made them the perfect seed cells for treating a wide range of diseases. Afte...

Full description

Saved in:
Bibliographic Details
Main Authors: Xinjuan Liu (Author), Zekun Li (Author), Luyun Liu (Author), Ping Zhang (Author), Yue Wang (Author), Gang Ding (Author)
Format: Book
Published: Frontiers Media S.A., 2024-08-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_86921aa1c8d74e178e35ca0f1cea86ef
042 |a dc 
100 1 0 |a Xinjuan Liu  |e author 
700 1 0 |a Zekun Li  |e author 
700 1 0 |a Luyun Liu  |e author 
700 1 0 |a Ping Zhang  |e author 
700 1 0 |a Yue Wang  |e author 
700 1 0 |a Gang Ding  |e author 
245 0 0 |a Metformin-mediated effects on mesenchymal stem cells and mechanisms: proliferation, differentiation and aging 
260 |b Frontiers Media S.A.,   |c 2024-08-01T00:00:00Z. 
500 |a 1663-9812 
500 |a 10.3389/fphar.2024.1465697 
520 |a Mesenchymal stem cells (MSCs) are a type of pluripotent adult stem cell with strong self-renewal and multi-differentiation abilities. Their excellent biological traits, minimal immunogenicity, and abundant availability have made them the perfect seed cells for treating a wide range of diseases. After more than 60 years of clinical practice, metformin is currently one of the most commonly used hypoglycaemic drugs for type 2 diabetes in clinical practice. In addition, metformin has shown great potential in the treatment of various systemic diseases except for type 2 diabetes in recent years, and the mechanisms are involved with antioxidant stress, anti-inflammatory, and induced autophagy, etc. This article reviews the effects and the underlying mechanisms of metformin on the biological properties, including proliferation, multi-differentiation, and aging, of MSCs in vitro and in vivo with the aim of providing theoretical support for in-depth scientific research and clinical applications in MSCs-mediated disease treatment. 
546 |a EN 
690 |a mesenchymal stem cells 
690 |a metformin 
690 |a proliferation 
690 |a differentiation 
690 |a aging 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Frontiers in Pharmacology, Vol 15 (2024) 
787 0 |n https://www.frontiersin.org/articles/10.3389/fphar.2024.1465697/full 
787 0 |n https://doaj.org/toc/1663-9812 
856 4 1 |u https://doaj.org/article/86921aa1c8d74e178e35ca0f1cea86ef  |z Connect to this object online.